Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ascites
ADR ID BADD_A00347
ADR Hierarchy
02      Cardiac disorders
02.05      Heart failures
02.05.04      Heart failure signs and symptoms
02.05.04.002      Ascites
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.05      Hepatobiliary signs and symptoms
09.01.05.003      Ascites
07      Gastrointestinal disorders
07.07      Peritoneal and retroperitoneal conditions
07.07.01      Peritoneal and retroperitoneal disorders
07.07.01.001      Ascites
Description A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity. [CTCAE] Accumulation or retention of free fluid within the peritoneal cavity. [MeSH]
MedDRA Code 10003445
MeSH ID D001201; D002915; D001202
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Ascites | Ascites chylous | Chylous ascites | Peritoneal effusion | Peritoneal effusion (chronic) | Ascites grade 1 | Ascites grade 3 | Ascites grade 2 | Perihepatic effusion
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02483Ribociclib0.000839%
BADD_D02485Talazoparib0.000112%
BADD_D02489Neratinib--
BADD_D02498Abemaciclib--
BADD_D02500Alpelisib0.000280%
BADD_D02503Telotristat ethyl-
BADD_D02504Lorlatinib0.000280%
BADD_D02505Gilteritinib0.000112%
BADD_D02509Brigatinib0.000168%
BADD_D02510Rucaparib0.001399%
BADD_D02524Ivosidenib0.000940%
BADD_D02553Entrectinib0.000168%
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02569Magnesium0.000294%
BADD_D02582Pemigatinib0.000112%
BADD_D02585Pralsetinib0.000224%
BADD_D02593Selpercatinib0.000392%
The 7th Page    First    Pre   7    Total 7 Pages